Free Trial

Profound Medical (PROF) SEC Filings & 10K Form

Profound Medical logo
$7.35
+0.08 (+1.10%)
(As of 11/1/2024 ET)

Recent Profound Medical SEC Filings

DateFilerForm TypeView
10/17/2024
3:45 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
3:30 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
8:42 AM
LETKO, BROSSEAU & ASSOCIATES INC (Filed by)
Profound Medical (Subject)
Form SCHEDULE 13G/A
09/23/2024
3:42 PM
Jordan-Cornet Helen (Reporting)
Profound Medical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
7:15 AM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2024
5:02 AM
Profound Medical (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/04/2024
4:02 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
11:15 AM
Jordan-Cornet Helen (Reporting)
Profound Medical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
12:31 PM
Jordan-Cornet Helen (Reporting)
Profound Medical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
6:50 AM
BDC CAPITAL INC. (Filed by)
Profound Medical (Subject)
Form SC 13G/A
07/18/2024
3:45 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
11:15 PM
Profound Medical (Filer)
Form EFFECT
07/10/2024
5:37 PM
Profound Medical (Filer)
Form F-10/A
06/14/2024
4:23 PM
Profound Medical (Subject)
Form F-X
Appointment of agent for service of process and undertaking  
06/03/2024
3:30 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
8:30 AM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
3:30 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
3:20 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
6:55 AM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2024
11:31 AM
Goodman Abbey (Reporting)
Profound Medical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:42 PM
Profound Medical (Filer)
Form 40-F
Registration statement pursuant to Section 12 or annual report pursuant to Section 13(a) or 15(d)
02/27/2024
7:00 AM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
3:45 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
1:37 PM
LETKO, BROSSEAU & ASSOCIATES INC (Filed by)
Profound Medical (Subject)
Form SC 13G/A
02/09/2024
6:59 AM
FIL Ltd (Filed by)
Profound Medical (Subject)
Form SC 13G/A
01/16/2024
3:45 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/11/2024
3:42 PM
Profound Medical (Subject)
Form SC 13G
01/11/2024
3:42 PM
DASEKE DON R (Filed by)
DASEKE DON R (Filed by)
Profound Medical (Subject)
Form SC 13G
01/02/2024
4:28 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/28/2023
4:19 PM
Profound Medical (Filer)
Form SUPPL
12/28/2023
4:23 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/28/2023
5:01 AM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
3:41 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
3:24 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
3:28 PM
Profound Medical (Filer)
Form SUPPL
11/08/2023
7:00 AM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/03/2023
7:10 AM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/02/2023
3:10 PM
Profound Medical (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PROF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners